Press Releases | Alexion Pharmaceuticals, Inc

About Alexion
Patient Focus
Products
Research & Development
Responsibility
Careers
Select a Country
- North America
  - Canada
  - USA
- Latin America
  - Argentina
  - Brazil
  - Colombia
  - Mexico
- Europe, the Middle East & Africa
  - Alexion Europe
  - Belgium
  - Denmark
  - France
  - Germany
  - Ireland
  - Italy
  - Netherlands
  - Norway
  - Russia
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - UAE
  - UK
- Asia Pacific
  - Australia
  - China
  - India
  - Japan
Investors
News
Contact

Home
»
Newsroom
»
Press Releases

Press Releases

All News Releases

Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute
January 5, 2009
HTML PDF
Alexion to Present at the 27th Annual JP Morgan Healthcare Conference
January 5, 2009
HTML PDF
Soliris® Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH
December 9, 2008
HTML PDF
Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH
December 8, 2008
HTML PDF
First Clinical Experience With Soliris® in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting
December 7, 2008
HTML PDF
Alexion to Present at the 20th Annual Piper Jaffray Health Care Conference
November 25, 2008
HTML PDF
David W. Keiser to Retire as President of Alexion
November 11, 2008
HTML PDF
Researchers to Present Additional Data on Soliris® (eculizumab) for the Treatment of PNH at the ASH Annual Meeting
November 10, 2008
HTML PDF
Alexion to Present at Investor Conferences
November 4, 2008
HTML PDF
Alexion Reports Third Quarter 2008 Results
October 23, 2008
HTML PDF